Wyndeham Wins GBP16.5m Printing Contracts

Wyndeham Press Group has been awarded two significant contracts with a total estimated value of GBP16.5m.

Wyndeham Press Group has been awarded two significant contracts with a total estimated value of GBP16.5m.

Wyndeham's integrated services were instrumental, according to the group, in wining a GBP9m Astron Group contract.

Wyndeham has been introducing a more integrated business model to take advantage of cross-selling opportunities and to ensure that its subsidiaries work closely together, it commented.

That approach has already reaped benefits with the award of the contract by Astron Group, one of the largest and most successful information logistics organisations in Europe, servicing private, public and business process outsourcing markets.

The contract will initially run for three years, with an estimated value of GBP3m per annum.

Under the contract Wyndeham will be responsible for providing print services for the Astron Group, which will be supplied through an integrated set-up that spans Wyndeham's subsidiaries.

In addition, Wyndeham Heron has won the GBP7.5m British Medical Journal (BMJ) and News Review contracts.

Wyndeham Heron has been awarded a three-year contract to print The British Medical Journal, the leading, 160 year-old publication for the medical profession in the UK.

The estimated value of the contract is GBP2.5m per annum.

The contract was won, following a competitive tender against 15 print companies because the BMJ and New Review team considered Wyndeham Heron to represent the best combination of facilities, capacity, scheduling and customer service.

The British Medical Journal and News Review consists of up to seven published elements every week, with print runs ranging from 30,000 to 120,000 copies of between 16 pages and 160 pages per copy.

Bryan Bedson, chief executive of Wyndeham commented: "We are pleased to see the early benefits of our move to further integrate our businesses, with the award of the Astron contract.

The award of the British Medical Journal contract also provides further evidence that our strategy to invest in technology is proving successful.".

Back to top